Life Sciences | Monitoring the Pulse of the Life Sciences Industry
Blogs

Life Sciences

Monitoring the Pulse of the Life Sciences Industry

Shared Investigator Platform (SIP) Strengths And Struggles

At any given time, a principal investigator (PI) can be working on one or more studies for a single sponsor company, or multiple studies for multiple sponsors. Likewise, each sponsor runs its clinical trials its own way, using its preferred technology and processes. And, often times, the technology and/or processes differ from study to study, […]

Read more

Release Notes: Oracle/Perficient’s Clinical Apps [December 2017]

Perficient’s Life Sciences practice regularly monitors the software release notes for several Oracle Health Sciences applications, as well as our own clinical and safety systems. The systems covered in our review are: Oracle Systems Argus Safety Oracle Clinical/Remote Data Capture (OC/RDC) Thesaurus Management System (TMS) Perficient Systems ASCEND (Siebel CTMS) Generally speaking, we review release […]

Read more

Clinical Study Migrations: Technical Things to Consider

There are a number of essential technical considerations that should be evaluated when migrating clinical studies from one database to another. Is the target database new or does the incoming data need to be “merged” into an existing database? What if the source application has been customized? What obstacles can be expected? Where does regulatory […]

Read more

Top 5 Pharma & Medical Device Blog Posts From November 2017

Now that December is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in November – they’re ranked in order of popularity, with number one being the most viewed piece. Top 25 Biotech Companies European […]

Read more

EMA Issues Brexit Guidance To Pharma

Pharmaceutical companies selling their products in the UK need to consider the impact Brexit will have on their operations. Some changes will need to be made before the UK leaves the European Union on March 30, 2019. In a press release, the European Medicines Agency (EMA) said: “The guidance document outlines the practical and simplified […]

Read more

How To Fix Problems With Clinical Site And Investigator Payments

This is perhaps the biggest complaint we hear from both sponsors/contract research organizations (CROs) and sites/investigators. Sponsors and CROs dedicate countless resources to researching and addressing payment questions and concerns raised by site personnel, and site personnel often feel frustrated, undervalued, and distrustful of sponsors and CROs that do not pay them as promised. When […]

Read more

European Medicines Agency (EMA) Is Moving To Amsterdam

The European Medicines Agency (EMA) is will be moving its offices from London to Amsterdam, due to the UK’s decision to withdraw from the European Union. According to a press release issued by the EMA, the relocation effort needs to be completed by the end of March 2019. The EMA currently employs close to 900 […]

Read more

How To Fix Having Outdated Contact Details For Clinical Sites

At first glance, having outdated contact information for sites might seem like a pretty minor issue. But when it results in delays related to required documents, monitoring visits, or clinical supplies, the issue quickly becomes more serious. It might be easy to keep a sponsor or contract research organization (CRO) in the loop when a […]

Read more

Top 25 Biotech Companies

We’re all intrigued by rankings and flock to them for good reason. When it comes to ranking companies by market capitalization, you can assume that the named companies are leaders in their own right. They never stop innovating. They never stop changing. They never stop investing in their business. These are companies that we can […]

Read more

How To Fix Cumbersome Site Monitoring Visits To Clinical Sites

While sponsors, contract research organizations (CROs), and clinical sites all acknowledge that site monitoring is a necessary part of ensuring clinical trials are run in compliance with governing regulations and protocols, it can be a rather burdensome process, both for monitors and for sites. Monitors struggle with scheduling the visits, having access to everything they […]

Read more

Perficient Life Sciences

We monitor the pulse of the life sciences industry, from clinical to digital. Read about the trends, insights, successes, warnings, and solutions that move science forward.

Archives